ScinoPharm to manufacture anti-obesity drug for VIVUS

Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2012

Singapore: ScinoPharm's Taiwan facility will provide commercial manufacturing of topiramate active pharmaceutical ingredient for VIVUS's Qsymia, a new drug for the treatment of obesity appr...Read more

Samsung Bioepis, Merck in biosimilars deal

Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

Singapore: Seoul-based Samsung Bioepis and MSD, known as Merck in the US and Canada, have entered into an agreement to develop and commercialize multiple pre-specified and undisclosed biosi...Read more

Ninad Deshpanday is Kemwell R&D president

Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

Bangalore: India-based Kemwell Biopharma appointed Dr Ninad Deshpanday as president of R&D. Dr Deshpanday has over 22 years of experience in diverse international roles in the pharmaceu...Read more

Companies allocate 11% budget for CMO: Report

Contract Manufacturing |  Analysis | By BioSpectrum Bureau  | 0 Comment | 26 Nov, 2013

Singapore: Global contract manufacturing market is growing steadily with firms allocating up to four percent of annual organization revenues for contract manufacturing organization (CMO) se...Read more

US Governor visits Jubilant office in India

Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 08 Oct, 2012

New Delhi: Ms Christine Gregoire, governor of Washington, the US, visited the headquarters of Jubilant Life Sciences at Noida, India. The integrated pharmaceuticals and life sciences compan...Read more

CMOs look towards Asia to reduce cost by 50%

Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 05 Nov, 2012

Singapore: Global contract manufacturing organizations (CMOs) are set to steadily become more and more popular, as Western pharmaceutical companies outsource production to Asian countries i...Read more

ProBioGen offers productivity-boosting technology

Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

Singapore: ProBioGen, a German contract development and manufacturing organization, has developed and implemented the Pathway Modulator Technology, a permanent modification of animal cell l...Read more

ScinoPharm to invest in oncological products plant

Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

Singapore: ScinoPharm will invest NT$1.13 billion (approximately $37.6 million) in the construction of a high potency cytotoxic injectable plant suitable for production of oncological injec...Read more